Molecular Biology

• Knowing the IASLC: introduction, history, work and future perspectives.
• Epidemiology and perspectives of Lung Cancer in Latin America.
• Clinical Lung Cancer research worldwide.
• Clinical Lung Cancer Research in Latin-America
• Meet the pathway in Lung Cancer I: EGFR, ALK, ROS1, MET, RAS.
• Meet the pathway in Lung Cancer II: RET, NRTK, HER2, PI3K, BRAF and others.
• Guest Starring: The molecular pathologist and their integration in a multidisciplinary team.
• Understanding new technologies: NGS in clinical practice.
• The role of biobank in clinical research: Molecular tumor board, implementation
  and benefits.
• Update of gold standards in Lung Cancer target therapy.

Implementation of Clinical Trials

• Clinical Trials: Definitions and examples
• Statistics: Bullet points and definitions.
• Statistics: How to integrate biomarkers in the new clinical trial designs: basket and umbrella.
• Understanding the “current holy grail” of Lung Cancer: Immunotherapy biological rationale.
• Current treatments in immunotherapy for Lung Cancer: critical view on evidence and response assesment.
• What’s after the PD1- PDL1 era? New combinations and new biomarkers.
• How to design a clinical trial in Lung Cancer.
• Early research in radiation oncology: SBRT and new drugs.
• How to read a paper? How to write a paper?
• Good Clinical Practice in Lung Cancer

GCP and Regulatory Affairs

• Same target, different trial designs, same conclusions? Stastistician ́s and oncologist ́s point of view.
• Robotic surgery: the future for lung cancer surgical treatment?
• Regulatory agencies: FDA, EMA and
  local (Peru, Chile, Argentina, others)
  Role of Industry, University and CRO in clinical research.
• Improving Networking in your region.
• Survey and GCP test.